Clinical Trials Browser

Interventional × Loperamide × Clear all

NCT04038619 2026-03-18

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Phase 1 Recruiting

BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase 1/2 Completed

224 enrolled 15 charts

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Phase 2 Completed

34 enrolled 22 charts

Sarcoma, Alveolar Soft Part

NCT02057133 2026-01-26

A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

Phase 1 Active not recruiting

Breast Neoplasms

NCT04216329 2026-01-23

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Phase 1 Active not recruiting

11 enrolled 19 charts

Glioblastoma, Gliosarcoma

NCT06865677 2026-01-21

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Phase 2 Terminated

2 enrolled 7 charts

Recurrence

NCT06424522 2026-01-20

A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

Phase NA Recruiting

Gastrointestinal

Low Anterior Resection Syndrome, Rectal Neoplasms

NCT05520723 2025-12-04

PRIMED

Phase 2 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06892093 2025-09-08

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Phase NA Recruiting

Breast Neoplasms, Diarrhea

NCT03094052 2025-06-26

Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib

Phase 2 Completed

11 enrolled 12 charts

Breast Neoplasms

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05252988 2025-04-01

DIANER

Phase 2 Active not recruiting

Breast Neoplasms

NCT04823065 2024-05-13

4FMFES-PET Imaging of Endometrial and Ovarian Cancers

Phase 1/2 Completed

Ovarian Neoplasms, Endometrial Neoplasms

NCT00003057 2023-06-18

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

NCT04366713 2023-02-10

A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib

Phase 2 Completed

6 enrolled 8 charts

Breast Neoplasms

NCT05252546 2022-12-23

Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects

Phase 1 Completed

Breast Neoplasms

NCT04447443 2021-08-06

Impact of Dietary Fiber as Prebiotics on Chemotherapy-related Diarrhea in Patients With Gastrointestinal Tumors

Phase NA Withdrawn

Chemotherapy-related Diarrhea

NCT04736186 2021-02-03

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

Phase 2/3 Unknown

Breast Neoplasms, Diarrhea

NCT02441946 2020-06-17

neoMONARCH

Phase 2 Completed

224 enrolled 20 charts

Breast Neoplasms

NCT03705442 2018-10-15

Probat-tmcc-17

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

NCT00401388 2018-03-07

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

Phase 2 Completed

Chondrosarcoma, Sarcoma, Alveolar Soft Part

NCT02266849 2016-10-11

Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Phase 3 Terminated

Gastrointestinal

Colitis, Ulcerative, Rectal Neoplasms, Short Bowel Syndrome

NCT02323516 2015-12-08

ASPIDIA

Phase 2 Withdrawn

Neoplasms